GLP1 Agonists and Dietary Fiber May Reduce VTE Risk and Improve GVHD Outcomes

Glucagon-like peptide 1 (GLP1) receptor agonists were shown to be associated with a reduced risk of venous thromboembolism (VTE), while high dietary fiber intake was shown to enhance microbiome health, lower graft-versus-host disease (GVHD) severity, and improve overall survival following allogeneic hematopoietic cell transplantation.

Check Also

Seasonal Wellness: Why Dry Fruits Are A Must-Have During Winter?

Seasonal Wellness: Why Dry Fruits Are A Must-Have During Winter?

As winter sets in, our bodies require extra nourishment to combat the chilly weather and …

Leave a Reply

Your email address will not be published. Required fields are marked *